Details of Drug

Drug General Information (ID: D1316)
Drug Name	Potassium acetate
Drug Type	Small molecule
Drug Synonymous	Potassium Acetate In Plastic Container Click to Show/Hide
Disease Class	GB70: Urinary tract disease
Therapeutic Class	Minerals And Electrolytes
Structure
Structure	3D Structure		2D Structure
Formula	C2H3KO2
InChI	1S/C2H4O2.K/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1
InChIKey	SCVFZCLFOSHCOH-UHFFFAOYSA-M
Canonical SMILES	CC(=O)[O-].[K+]
External Link
	Pubchem ID	517044
	CAS Number	127-08-2
	CHEBI ID	32029
	TTD ID	D0C1PY

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects BM029 Altered urine pH BM058 Increased risk of hyperkalemia BM064 Increased risk of hypoglycemia
Relation Graph

Full list of drugs interacting with Potassium acetate
Affected excretion pathways
	Altered urine pH					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1025		Methotrexate	C20H22N8O5	126941	Minor		Inter Info	[76], [77], [78]
Pharmacodynamic additive effects
	Increased risk of hyperkalemia					Drug Num: 25
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0058		Amiloride	C6H8ClN7O	16231	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D0138		Azilsartan medoxomil	C30H24N4O8	135409642	Major		Inter Info	[17], [23], [2], [15], [24], [25], [21], [19], [10], [9], [26]
D0156		Benazepril	C24H28N2O5	5362124	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D0254		Captopril	C9H15NO3S	44093	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D0567		Enalapril	C20H28N2O5	5388962	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D0585		Eplerenone	C24H30O6	443872	Major		Inter Info	[3], [40]
D0587		Eprosartan	C23H24N2O4S	5281037	Major		Inter Info	[17], [23], [2], [15], [24], [25], [21], [19], [10], [9], [26]
D0695		Fosinopril	C30H46NO7P	55891	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D0844		Irbesartan	C25H28N6O	3749	Major		Inter Info	[15], [23], [17], [26], [24], [21], [10], [9], [19], [2], [25]
D0938		Lisinopril	C21H31N3O5	5362119	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D0954		Losartan	C22H23ClN6O	3961	Major		Inter Info	[17], [23], [2], [15], [24], [25], [21], [19], [10], [9], [26]
D1082		Moexipril	C27H34N2O7	91270	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D1170		Olmesartan	C24H26N6O3	158781	Major		Inter Info	[17], [23], [2], [15], [24], [25], [21], [19], [10], [9], [26]
D1256		Perindopril	C19H32N2O5	107807	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D1369		Quinapril	C25H30N2O5	54892	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D1379		Ramipril	C23H32N2O5	5362129	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D1501		Spironolactone	C24H32O4S	5833	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D1545		Telmisartan	C33H30N4O2	65999	Major		Inter Info	[17], [23], [2], [15], [24], [25], [21], [19], [10], [9], [26]
D1618		Trandolapril	C24H34N2O5	5484727	Major		Inter Info	[13], [27], [25], [21], [28], [29], [9], [30], [19], [10], [31], [16], [32], [17], [33], [15], [34], [2], [35], [26], [36], [37], [38], [39]
D1631		Triamterene	C12H11N7	5546	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]
D1645		Trimethoprim	C14H18N4O3	5578	Major		Inter Info	[41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [9], [10], [55], [56], [57], [58], [59], [60], [61], [21], [22], [62], [19], [3], [63], [64], [65], [66], [67], [68], [69]
D1679		Valsartan	C24H29N5O3	60846	Major		Inter Info	[17], [23], [2], [15], [24], [25], [21], [19], [10], [9], [26]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[70]
D0536		Drospirenone	C24H30O3	68873	Moderate		Inter Info	[71], [16]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[72]
	Increased risk of hypoglycemia					Drug Num: 14
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0807		Insulin aspart (aspart protamine)	C256H381N65O79S6	118984445	Minor		Inter Info	[73], [74], [75]
D0808		Insulin aspart (aspart)	C256H381N65O79S6	118984445	Minor		Inter Info	[73], [74], [75]
D0809		Insulin degludec	C274H411N65O81S6	118984462	Minor		Inter Info	[73], [74], [75]
D0810		Insulin detemir	C267H402N64O76S6	16137271	Minor		Inter Info	[73], [74], [75]
D0811		Insulin glargine	C267H404N72O78S6	118984454	Minor		Inter Info	[73], [74], [75]
D0812		Insulin glulisine	C258H384N64O78S6	16136701	Minor		Inter Info	[73], [74], [75]
D0813		Insulin human	C257H383N65O77S6	118984375	Minor		Inter Info	[73], [74], [75]
D0814		Insulin human (inhalation, rapid acting)	C257H383N65O77S6	118984375	Minor		Inter Info	[73], [74], [75]
D0815		Insulin human (isophane)	C257H383N65O77S6	118984375	Minor		Inter Info	[73], [74], [75]
D0816		Insulin human (regular)	C257H383N65O77S6	118984375	Minor		Inter Info	[73], [74], [75]
D0817		Insulin human (zinc extended)	C257H383N65O77S6	118984375	Minor		Inter Info	[73], [74], [75]
D0818		Insulin human (zinc)	C257H383N65O77S6	118984375	Minor		Inter Info	[73], [74], [75]
D0819		Insulin lispro	C257H389N65O77S6	16132438	Minor		Inter Info	[73], [74], [75]
D0820		Insulin lispro (protamine)	C257H389N65O77S6	16132438	Minor		Inter Info	[73], [74], [75]

References
1	McNay JL, Oran E "Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870)." Metabolism 19 (1970): 58-70. [PMID: 5410663]
2	Jarman PR, Kehely AM, Mather HM "Hyperkalaemia in diabetes: prevalence and associations." Postgrad Med J 71 (1995): 551-2. [PMID: 7479468]
3	Marcy TR, Ripley TL "Aldosterone antagonists in the treatment of heart failure." Am J Health Syst Pharm 63 (2006): 49-58. [PMID: 16373465]
4	Berry C, McMurray JJ "Serious adverse events experienced by patients with chronic heart failure taking spironolactone." Heart 85 (2001): E8. [PMID: 11250985]
5	Bozkurt B, Agoston I, Knowlton AA "Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines." J Am Coll Cardiol 41 (2003): 211-4. [PMID: 12535810]
6	Shapiro S, Slone D, Lewis GP, Jick H "Fatal drug reactions among medical inpatients." JAMA 216 (1971): 467-72. [PMID: 5107928]
7	Product Information. Aldactone (spironolactone). Searle, Skokie, IL.
8	Masoudi FA, Gross CP, Wang Y, et al. "Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001." Circulation 112 (2005): 39-47. [PMID: 15983243]
9	Lawson DH, O'Connor PC, Jick H "Drug attributed alterations in potassium handling in congestive cardiac failure." Eur J Clin Pharmacol 23 (1982): 21-5. [PMID: 7128669]
10	Lawson DH "Adverse reactions to potassium chloride." Q J Med 43 (1974): 433-40. [PMID: 4424028]
11	O'Reilly MV, Murnaghan DP, Williams MB "Transvenous pacemaker failure induced by hyperkalemia." JAMA 228 (1974): 336-7. [PMID: 4406078]
12	Greenblatt DJ, Koch-Weser J "Adverse reactions to spironolactone: a report from the Boston Collaborative Drug Surveillance Program." JAMA 225 (1973): 40-3. [PMID: 4740303]
13	Product Information. K-Dur (potassium chloride). Schering Laboratories, Kenilworth, NJ.
14	Walker BR, Hoppe RC, Alexander F "Effect of triamterene on the renal clearance of calcium, magnesium, phosphate, and uric acid in man." Clin Pharmacol Ther 13 (1972): 245-50. [PMID: 4552822]
15	Jarman PR, Mather HM "Diabetes may be independent risk factor for hyperkalaemia." BMJ 327 (2003): 812. [PMID: 14525902]
16	Ponce SP, Jennings AE, Madias NE, Harrington JT "Drug-induced hyperkalemia." Medicine (Baltimore) 64 (1985): 357-70. [PMID: 2865667]
17	Walmsley RN, White GH, Cain M, McCarthy PJ, Booth J "Hyperkalemia in the elderly." Clin Chem 30 (1984): 1409-12. [PMID: 6744599]
18	Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D "Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study." BMJ 327 (2003): 1141-2. [PMID: 14615339]
19	Perazella MA "Drug-induced hyperkalemia: old culprits and new offenders." Am J Med 109 (2000): 307-14. [PMID: 10996582]
20	Mashford ML, Robertson MB "Spironolactone and ammonium and potassium chloride." Br Med J 4 (1972): 298-9. [PMID: 5083905]
21	Perazella MA, Mahnensmith RL "Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis." J Gen Intern Med 12 (1997): 646-56. [PMID: 9346463]
22	Martin J, Mourton S, Nicholls G "Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient." N Z Med J 116 (2003): U542. [PMID: 14513088]
23	Product Information. Cozaar (losartan). Merck & Co, Inc, West Point, PA.
24	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
25	Large DM, Carr PH, Laing I, Davies M "Hyperkalaemia in diabetes mellitus--potential hazards of coexisting hyporeninaemic hypoaldosteronism." Postgrad Med J 60 (1984): 370-3. [PMID: 6377287]
26	Obialo CI, Ofili EO, Mirza T "Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease." Am J Cardiol 90 (2002): 663-5. [PMID: 12231103]
27	Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS, Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association "Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association." Circulation 104 (2001): 1985-91. [PMID: 11602506]
28	Schuna AA, Schmidt GR, Pitterle ME "Serum potassium concentrations after initiation of captopril therapy." Clin Pharm 5 (1986): 920-3. [PMID: 3536269]
29	Atlas SA, Case DB, Sealey JE, Laragh JH, McKinstry DN "Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natriuresis." Hypertension 1 (1979): 279-80. [PMID: 399239]
30	Graves JW "Hyperkalemia due to a potassium-based water softener." N Engl J Med 339 (1998): 1790-1. [PMID: 9867563]
31	Packer M, Lee WH "Provocation of hyper- and hypokalemic sudden death during treatment with and withdrawal of converting-enzyme inhibition in severe chronic congestive heart failure." Am J Cardiol 57 (1986): 347-8. [PMID: 3004185]
32	Good CB, McDermott L "Diet and serum potassium in patients on ACE inhibitors." JAMA 274 (1995): 538. [PMID: 7629980]
33	Burnakis TG, Mioduch HJ "Combined therapy with captopril and potassium supplementation: a potential for hyperkalemia." Arch Intern Med 144 (1984): 2371-2. [PMID: 6391404]
34	Stoltz ML, Andrews CE Jr "Severe hyperkalemia during very-low-calorie diets and angiotensin converting enzyme use ." JAMA 264 (1990): 2737-8. [PMID: 2172575]
35	Reardon LC, Macpherson DS "Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?" Arch Intern Med 158 (1998): 26-32. [PMID: 9437375]
36	Chan TY, Critchley JA "Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements." Drug Saf 7 (1992): 159-61. [PMID: 1605901]
37	Warren SE, O'Connor DT "Hyperkalemia resulting from captopril administration." JAMA 244 (1980): 2551-2. [PMID: 7001073]
38	Ray K, Dorman S, Watson R "Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction." J Hum Hypertens 13 (1999): 717-20. [PMID: 10516744]
39	Speirs CJ, Dollery CT, Inman WH, et al "Postmarketing surveillance of enalapril II: investigation of the potential role of enalapril in deaths with renal failure." Br Med J 297 (1988): 830-2. [PMID: 2846102]
40	Product Information. Inspra (eplerenone). Searle, Chicago, IL.
41	Canaday DH, Johnson JR "Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole." Ann Intern Med 120 (1994): 438. [PMID: 8304666]
42	Witt JM, Koo JM, Danielson BD "Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men." Ann Pharmacother 30 (1996): 347-50. [PMID: 8729886]
43	Alappan R, Perazella MA, Buller GK "Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole." Ann Intern Med 124 (1996): 316-20. [PMID: 8554227]
44	Perlmutter EP, Sweeney D, Herskovits G, Kleiner M "Case report: severe hyperkalemia in a geriatric patient receiving standard doses of trimethoprim-sulfamethoxazole." Am J Med Sci 311 (1996): 84-5. [PMID: 8615380]
45	Perazella MA, Mahnensmith RL "Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose." Clin Nephrol 46 (1996): 187-92. [PMID: 8879854]
46	Marinella MA "Trimethoprim-sulfamethoxazole associated with hyperkalemia." West J Med 167 (1997): 356-8. [PMID: 9392994]
47	Hsu I, Wordell CJ "Hyperkalemia and high-dose trimethoprim/sulfamethoxazole." Ann Pharmacother 29 (1995): 427-9. [PMID: 7633023]
48	Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM "Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study." Arch Intern Med 170 (2010): 1045-9. [PMID: 20585070]
49	Velazquez H, Perazella MA, Wright FS, Ellison DH "Renal mechanism of trimethoprim-induced hyperkalemia." Ann Intern Med 119 (1993): 296-301. [PMID: 8328738]
50	Marinella MA "Reversible hyperkalemia associated with trimethoprim-sulfamethoxazole." Am J Med Sci 310 (1995): 115-7. [PMID: 7668307]
51	Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR "Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS." N Engl J Med 328 (1993): 703-6. [PMID: 8433730]
52	Lin SH, Kuo AA, Yu FC, Lin YF "Reversible voltage-dependent distal renal tubular acidosis in a patient receiving standaard doses of trimethoprim-sulphamethoxazole." Nephrol Dial Transplant 12 (1997): 1031-33. [PMID: 9175064]
53	Thomas RJ "Severe hyperkalemia with trimethoprim-quinapril." Ann Pharmacother 30 (1996): 413-4. [PMID: 8729901]
54	Marinella MA "Severe hyperkalemia associated with trimethoprim-sulfamethoxazole and spironolactone." Infect Dis Clin Pract 6 (1997): 256-8.
55	Perazella MA, Alappan R, Buller GK "Hyperkalemia and trimethoprim-sulfamethoxazole." Ann Intern Med 125 (1996): 1015. [PMID: 8929019]
56	Noto H, Kaneko Y, Takano T, Kurokawa K "Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia." Intern Med 34 (1995): 96-9. [PMID: 7727887]
57	Greenberg S, Reiser IW, Chou SY, Porush JG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.?Ann Intern Med. 1993;119(4):291-295. [PMID: 8328737]
58	Mihm LB, Rathbun RC, Resmantargoff BH "Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome." Pharmacotherapy 15 (1995): 793-7. [PMID: 8602391]
59	Product Information. Bactrim (trimethoprim-sulfamethoxazole). Roche Laboratories, Nutley, NJ.
60	Mori H, Kuroda Y, Imamura S, et al "Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole." Intern Med 42 (2003): 665-9. [PMID: 12924488]
61	Lee SW, Park SW, Kang JM "Intraoperative hyperkalemia induced by administration of trimethoprim-sulfamethoxazole in a patient receiving angiotensin receptor blockers." J Clin Anesth 26 (2014): 427-8. [PMID: 25128254]
62	Modest GA, Price B, Mascoli N "Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole." Ann Intern Med 120 (1994): 437. [PMID: 8304664]
63	Koc M, Bihorac A, Ozener CI, Kantarci G, Akoglu E "Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole." Am J Kidney Dis 36 (2000): u59-64. [PMID: 10977811]
64	Bugge JF "Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs." J Intern Med 240 (1996): 249-51. [PMID: 8918517]
65	Smith GW, Cohen SB "Hyperkalaemia and non-oliguric renal failure associated with trimethoprim." Br Med J 308 (1994): 454. [PMID: 8124180]
66	Eiam-Ong S, Kurtzman NA, Sabatini S "Studies on the mechanism of trimethoprim-induced hyperkalemia." Kidney Int 49 (1996): 1372-8. [PMID: 8731102]
67	Fouche R, Bernardin G, Roger PM, Corcelle P, Simler JM, Mattei M "Hyperkaliemia in a patient given high-dose trimethoprim-sulfamethoxazole." Presse Med 25 (1996): 2044. [PMID: 9082385]
68	Pennypacker LC, Mintzer J, Pitner J "Hyperkalemia in elderly patients receiving standard doses of trimethoprim-sulfamethoxazole." Ann Intern Med 120 (1994): 437. [PMID: 8304665]
69	Greenberg S, Reiser IW, Chou SY "Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy." Am J Kidney Dis 22 (1993): 603-6. [PMID: 8213804]
70	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
71	Product Information. Yasmin (drospirenone-ethinyl estradiol) Berlex Laboratories, Richmond, CA.
72	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
73	DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ "The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man." J Clin Invest 55 (1975): 845-55
74	Hiatt N, Davidson MB, Bonorris G "The effect of potassium chloride infusion on insulin secretion in vivo." Horm Metab Res 4 (1972): 64-8
75	Conn HO "Cirrhosis and diabetes. IV. Effect of potassium chloride administration on glucose and insulin metabolism." Am J Med Sci 259 (1970): 394-404
76	Nirenberg A, Mosende C, Mehta BM, Gisolfi AL, Rosen G "High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity." Cancer Treat Rep 61 (1977): 779-83. [PMID: 302143]
77	Sand TE, Jacobsen S "Effect of urine pH and flow on renal clearance of methotrexate." Eur J Clin Pharmacol 19 (1981): 453-6. [PMID: 7250179]
78	Stoller RG, Hande KR, Jacobs SA, Rosenberg SA, Chabner BA "Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity." N Engl J Med 297 (1977): 630-4. [PMID: 302412]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence